INTELLIGENT BIO SOLUTIONS INC. Proceeds from Issuance of Convertible Preferred Stock
INTELLIGENT BIO SOLUTIONS INC. (INBS) reported Proceeds from Issuance of Convertible Preferred Stock of $220.58 thousand for the 12-month period ending 2023-06-30, per its 10-K filed 2023-08-23.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock · last filed 2023-08-23
- INTELLIGENT BIO SOLUTIONS INC. proceeds from issuance of convertible preferred stock for the quarter ending 2023-06-30 was $0.00.
- INTELLIGENT BIO SOLUTIONS INC. proceeds from issuance of convertible preferred stock for the quarter ending 2023-03-31 was $0.00.
- INTELLIGENT BIO SOLUTIONS INC. proceeds from issuance of convertible preferred stock for the quarter ending 2021-06-30 was $0.00, a 100.00% decline year-over-year.
- INTELLIGENT BIO SOLUTIONS INC. proceeds from issuance of convertible preferred stock for the quarter ending 2021-03-31 was $0.00.
- INTELLIGENT BIO SOLUTIONS INC. proceeds from issuance of convertible preferred stock for fiscal 2023 was $220.58K.
- INTELLIGENT BIO SOLUTIONS INC. proceeds from issuance of convertible preferred stock for fiscal 2021 was $3.29M, a 229.06% increase from fiscal 2020.
- INTELLIGENT BIO SOLUTIONS INC. proceeds from issuance of convertible preferred stock for fiscal 2020 was $1.00M.
| Period end | Proceeds from Issuance of Convertible Preferred Stock 3 month | Proceeds from Issuance of Convertible Preferred Stock 6 month | Proceeds from Issuance of Convertible Preferred Stock 9 month | Proceeds from Issuance of Convertible Preferred Stock 12 month |
|---|---|---|---|---|
| 2023-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-08-23 | $0.00 derived: sum of 2 quarters · filed 2023-08-23 | $220.58K 10-K · filed 2023-08-23 | |
| 2023-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-11 | $220.58K 10-Q · filed 2023-05-11 | ||
| 2022-12-31 | $220.58K 10-Q · filed 2023-02-14 | |||
| 2021-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-22 | $0.00 derived: sum of 2 quarters · filed 2022-09-22 | $0.00 derived: sum of 3 quarters · filed 2022-09-22 | $3.29M 10-K · filed 2022-09-22 |
| 2021-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-16 | $0.00 derived: sum of 2 quarters · filed 2022-05-16 | $3.29M 10-Q · filed 2022-05-16 | $3.65M derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-02-11 | $3.29M 10-Q · filed 2022-02-11 | $3.65M derived: sum of 3 quarters · filed 2022-02-11 | $3.65M derived: sum of 4 quarters · filed 2022-02-11 |
| 2020-09-30 | $3.29M 10-Q · filed 2021-11-12 | $3.65M derived: sum of 2 quarters · filed 2021-11-12 | $3.65M derived: sum of 3 quarters · filed 2021-11-12 | |
| 2020-06-30 | $352.50K derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-16 | $352.50K derived: sum of 2 quarters · filed 2021-09-16 | $1.00M 10-K · filed 2021-09-16 | |
| 2020-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-13 | $648.75K 10-Q · filed 2021-05-13 | ||
| 2019-12-31 | $648.75K 10-Q · filed 2021-02-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |